Literature DB >> 23962995

Anterior versus posterior approach for treatment of cervical spondylotic myelopathy: a systematic review.

Brandon D Lawrence1, W Bradley Jacobs, Daniel C Norvell, Jeffrey T Hermsmeyer, Jens R Chapman, Darrel S Brodke.   

Abstract

STUDY
DESIGN: Systematic review.
OBJECTIVE: We performed a systematic review to determine the comparative effectiveness and safety profiles of anterior versus posterior decompression procedures for multilevel cervical spondylotic myelopathy (CSM). SUMMARY OF BACKGROUND DATA: CSM is a common cause of neurological dysfunction. It is well established that surgical decompression of the cervical spinal cord is an effective treatment option for CSM. Because of the lack of well-designed prospective studies, there remains a lack of consensus whether multilevel spondylotic compression is best treated via an anterior or posterior surgical route and whether one of these surgical approaches is superior in terms of patient outcomes and/or complication profiles.
METHODS: We conducted a systematic search for literature published through September 2012. We sought to identify comparative studies (e.g., randomized controlled trials, cohort studies) comparing anterior with posterior procedures in patients with 2-level or greater cord compression resulting in CSM. Standardized mean differences were calculated to allow comparisons of the change (i.e., improvement or decline) in scores between anterior and posterior surgical procedures by study. Clinical recommendations were made through a modified Delphi approach by applying the GRADE (Grading of Recommendation Assessment, Development and Evaluation)/AHRQ (Agency for Healthcare Research and Quality) criteria.
RESULTS: We identified 8 level III retrospective cohort studies that met the inclusion criteria from a total of 135 possible studies for review. With regard to effectiveness between the 2 approaches, improvements in JOA (Japanese Orthopaedic Association) scores were similar, whereas canal diameter change was larger after posterior surgery. With regard to safety, postoperative C5 palsy rates were similar, infection rates were lower with anterior surgery, and dysphagia rates were lower with posterior surgery.
CONCLUSION: This systematic review demonstrates that, for both effectiveness and safety, there is no clear advantage to either an anterior surgical approach or a posterior surgical approach when treating patients with multilevel CSM. With that, a surgical strategy developed on a patient-to-patient basis should be used to achieve optimal patient outcomes. In addition, development of a consensus for standardized reporting of outcome measures and complication profiles would facilitate improved comparisons across differing treatment centers and surgical techniques. EVIDENCE-BASED CLINICAL RECOMMENDATIONS: RECOMMENDATION: We recommend an individualized approach when treating patients with CSM accounting for pathoanatomical variations (ventral vs. dorsal, focal vs. diffuse, sagittal, dynamic instability) because there are similar outcomes between the anterior and posterior approaches with regard to effectiveness and safety. OVERALL STRENGTH OF EVIDENCE: Low. STRENGTH OF RECOMMENDATION: Strong.

Entities:  

Mesh:

Year:  2013        PMID: 23962995     DOI: 10.1097/BRS.0b013e3182a7eaaf

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  38 in total

Review 1.  Comparison of anterior approach versus posterior approach for the treatment of multilevel cervical spondylotic myelopathy.

Authors:  Jiaquan Luo; Kai Cao; Sheng Huang; Liangping Li; Ting Yu; Cong Cao; Rui Zhong; Ming Gong; Zhiyu Zhou; Xuenong Zou
Journal:  Eur Spine J       Date:  2015-04-04       Impact factor: 3.134

2.  Predictors of morbidity and mortality among patients with cervical spondylotic myelopathy treated surgically.

Authors:  I David Kaye; Bryan J Marascalchi; Angel E Macagno; Virginie A Lafage; John A Bendo; Peter G Passias
Journal:  Eur Spine J       Date:  2015-05-23       Impact factor: 3.134

3.  Smith-Robinson procedure with and without Caspar plating as a treatment for cervical spondylotic myelopathy: A 26-year follow-up of 23 patients.

Authors:  Benedikt W Burkhardt; Moritz Brielmaier; Karsten Schwerdtfeger; Salam Sharif; Joachim M Oertel
Journal:  Eur Spine J       Date:  2017-02-09       Impact factor: 3.134

4.  An in vitro evaluation of sagittal alignment in the cervical spine after insertion of supraphysiologic lordotic implants.

Authors:  Donald J Blaskiewicz; Jeffrey E Harris; Patrick P Han; Alexander W Turner; Gregory M Mundis
Journal:  Eur Spine J       Date:  2017-05-13       Impact factor: 3.134

5.  Surface Landmarks do not Correspond to Exact Levels of the Cervical Spine: References According to the Sex, Age and Height.

Authors:  Chang Hyun Oh; Gyu Yeul Ji; Seung Hwan Yoon; Dongkeun Hyun; Chun Gil Choi; Hyun Kyoung Lim; A Reum Jang
Journal:  Korean J Spine       Date:  2014-09-30

6.  Delayed postoperative C5 root palsy and the use of neurophysiologic monitoring.

Authors:  Steven Spitz; Daniel Felbaum; Nima Aghdam; Faheem Sandhu
Journal:  Eur Spine J       Date:  2015-10-03       Impact factor: 3.134

7.  Cervical spondylotic myelopathy: the prediction of outcome following surgical intervention in 93 patients using T1- and T2-weighted MRI scans.

Authors:  Hatem M I Salem; Khalid M I Salem; Filip Burget; Raj Bommireddy; Zdenek Klezl
Journal:  Eur Spine J       Date:  2015-06-16       Impact factor: 3.134

8.  Postoperative neck symptoms of posterior approach for cervical compressive myelopathy: Expansive open-door laminoplasty vs. segmental partial laminectomy.

Authors:  Koji Otani; Masumi Iwabuchi; Katsuhiko Sato; Shinichi Konno; Shinichi Kikuchi
Journal:  Fukushima J Med Sci       Date:  2018-05-18

9.  Posterior surgical treatment of cervical spondylotic myelopathy: review article.

Authors:  Paul D Kiely; John C Quinn; Jerry Y Du; Darren R Lebl
Journal:  HSS J       Date:  2015-02-10

Review 10.  Degenerative cervical myelopathy.

Authors:  So Kato; Michael Fehlings
Journal:  Curr Rev Musculoskelet Med       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.